Abstract
Tuberculosis (TB) is an important public health problem worldwilde due to AIDS epidemic, the advent of multidrug resistant strains (MDR) and the lack of new drugs in the market. TB is responsible for almost 3 millions deaths each year. According to WHO (World Health Organization), which declared tuberculosis a global health emergency in 1993, tuberculosis, without a coordinated control effort, will infect an estimated 1 billion people by 2020, killing 70 million. In spite of this problem, there is a lack of development of new TB drugs. For example, it has been nearly 35 years since the introduction of a new class of compounds for the treatment of TB. Thus, there is an urgent need for new drugs to fight against this disease. Considering that, this review aims promising drug candidates that are in development against TB.
Keywords: Tuberculosis, drugs, antimycobacterial activity
Recent Patents on Anti-Infective Drug Discovery
Title: Promising Drugs Against Tuberculosis
Volume: 1 Issue: 1
Author(s): Marcus V. N. de Souza
Affiliation:
Keywords: Tuberculosis, drugs, antimycobacterial activity
Abstract: Tuberculosis (TB) is an important public health problem worldwilde due to AIDS epidemic, the advent of multidrug resistant strains (MDR) and the lack of new drugs in the market. TB is responsible for almost 3 millions deaths each year. According to WHO (World Health Organization), which declared tuberculosis a global health emergency in 1993, tuberculosis, without a coordinated control effort, will infect an estimated 1 billion people by 2020, killing 70 million. In spite of this problem, there is a lack of development of new TB drugs. For example, it has been nearly 35 years since the introduction of a new class of compounds for the treatment of TB. Thus, there is an urgent need for new drugs to fight against this disease. Considering that, this review aims promising drug candidates that are in development against TB.
Export Options
About this article
Cite this article as:
de Souza V. N. Marcus, Promising Drugs Against Tuberculosis, Recent Patents on Anti-Infective Drug Discovery 2006; 1 (1) . https://dx.doi.org/10.2174/157489106775244163
DOI https://dx.doi.org/10.2174/157489106775244163 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Calcium Antagonists: A Ready Prescription for Treating Infectious Diseases?
Current Topics in Medicinal Chemistry The Protein Folding Problem: A Biophysical Enigma
Current Pharmaceutical Biotechnology A Recent Review On 3D-Printing: Scope and Challenges with Special Focus on Pharmaceutical Field
Current Pharmaceutical Design New Tuberculostatic Agents Targeting Nucleic Acid Biosynthesis: Drug Design using QSAR Approaches
Current Pharmaceutical Design Bedaquiline: A New Hope for Shorter and Better Anti-Tuberculosis Regimens
Recent Patents on Anti-Infective Drug Discovery Synthesis of 2,4,6-Trichlorophenyl Hydrazones and their Inhibitory Potential Against Glycation of Protein
Medicinal Chemistry Molecularly Imprinted Sol-Gel Materials for Medical Applications
Current Topics in Medicinal Chemistry Withdrawal Notice: Community-wide Screening of Symptomatic and Asymptomatic Infection of Mycobacterium tuberculosis in the Saharia tribe of India
Combinatorial Chemistry & High Throughput Screening Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Pyrrole-Based Hydrazones Synthesized and Evaluated In Vitro as Potential Tuberculostatics
Letters in Drug Design & Discovery The Potential of Ganoderma Lucidum as Antimicrobial Agent for Multidrug- Resistant Mycobacterium Tuberculosis
Anti-Infective Agents Further Perspectives on Diabetes: NeuroRegulation of Blood Glucose
Neuroscience and Biomedical Engineering (Discontinued) The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Thinking Outside the ‘Block’: Alternative Polymer Compositions for Micellar Drug Delivery
Current Topics in Medicinal Chemistry Glycosylation Employing Unprotected Carbohydrate Acceptor Components
Current Organic Chemistry Anti-mycobacterial Constituents from Medicinal Plants; A Review
Mini-Reviews in Medicinal Chemistry World Chagas Disease Day and the New Road Map for Neglected Tropical Diseases
Current Topics in Medicinal Chemistry COVID-19 and Coinfections: A Serious Health Threat Requires Combination of Diagnosis and Therapy
Infectious Disorders - Drug Targets Quinoxaline Derivatives: Novel and Selective Butyrylcholinesterase Inhibitors
Medicinal Chemistry Cytokines as Regulators of Atherosclerosis in Murine Models
Current Drug Targets